Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma has postponed shareholder consideration of a key resolution linked to its proposed all-share acquisition of Cannatrek Ltd., pushing the vote on issuing new ordinary and convertible shares from 22 April to 22 May 2026. The delay is intended to give both parties time to satisfy remaining conditions precedent to the scheme of arrangement, which they currently do not expect to present any major issues.
Other resolutions will still be put to shareholders at the general meeting as planned on 22 April, while the parties seek Federal Court orders to adjourn the second court hearing originally set for 24 April. An updated court date and revised indicative timetable for completing the scheme will be announced via the ASX and the company’s website, leaving investors watching for confirmation that regulatory and procedural hurdles are cleared on schedule.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd. is a global medicinal cannabis company with vertically integrated operations spanning Europe and Australia. It produces and distributes a diverse portfolio of cannabis-based medicines across Australia and more than a dozen export markets, leveraging three production facilities, including Europe’s largest, and a domestic distribution arm to capture value across the supply chain and support scalable growth.
The company is one of the top three suppliers in Australia and the largest supplier into France, while also serving Germany and the U.K., positioning it as a key player in high-growth medicinal cannabis markets. Its diversified revenue streams and relatively high net tangible asset position versus enterprise value offer investors leveraged exposure to global medicinal cannabis demand.
Average Trading Volume: 141,635
Technical Sentiment Signal: Sell
Current Market Cap: A$29.67M
Learn more about LGP stock on TipRanks’ Stock Analysis page.